
Vensana Capital is a venture capital and growth equity investment firm dedicated to partnering with entrepreneurs who seek to transform healthcare through breakthrough innovations in medical technology. The firm invests in development- and commercial-stage medtech companies, with offices in Minneapolis, MN and McLean, VA.
62% of their portfolio is in Healthcare. Deal activity decreased year-over-year (1 deal in the last 12 months vs 5 prior). Average disclosed round size is $57.6M (across 22 rounds with reported amounts).
Portfolio
21
Fund Size
$425M
Top Stage
Series B
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
24 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series A | $30M | Jan 2026 | |
| Series B | $125M | Jun 2025 | |
| SSpyGlass Pharma, Inc | Series D | — | Jun 2025 |
| Series D | $75M | Jun 2025 | |
| Series C | $106M | Dec 2024 | |
| Unknown | $32.5M | Oct 2024 | |
| Series C | $90M | Jul 2023 | |
| Series G | $50M | Apr 2023 | |
| Series B | — | Jan 2023 | |
| Series A | $20M | Nov 2022 | |
| Series C | $106M | Jan 2022 | |
| Series A | $21M | Dec 2021 | |
| CCleerly Coronary | Series B | $43M | Jun 2021 |
| Series B | $27.5M | Jan 2021 | |
| PPersonal Genome Diagnostics (PGDx) | Series C | $103M | Jan 2021 |
| Series D | $70M | Oct 2020 | |
| Unknown | $50M | Jul 2020 | |
| Series C | $103M | Jan 2014 | |
| AAlleviant Medical, Inc. | Unknown | $75M | — |
| VVesper Medical Inc | Unknown | $37M | — |
| LLuna Health | Series A | $23.6M | — |
| Series B | $20M | — | |
| Series B | $30M | — | |
| Series A | $30M | — |
Top Co-Investors
New Enterprise Associates10 shared
Sands Capital6 shared
Gilde Healthcare5 shared
Lightstone Ventures3 shared
New Leaf Venture Partners3 shared
LRVHealth3 shared
The Cigna Group Ventures3 shared
DigiTx Partners3 shared
Vertex Ventures HC3 shared
Samsara BioCapital3 shared
Canaan Partners2 shared
Morgenthaler Ventures2 shared
Endeavour Vision2 shared
Catalio Capital Management2 shared
Cowen Healthcare Investments2 shared
Northpond Ventures2 shared
Windham Capital Partners2 shared
PFM Health Sciences2 shared
Rock Springs Capital2 shared
Last updated: 7 October 2026